Literature DB >> 11029610

Further characterization of MHC haplotypes demonstrates conservation telomeric of HLA-A: update of the 4AOH and 10IHW cell panels.

S K Cattley1, J F Williamson, G K Tay, O P Martinez, S Gaudieri, R L Dawkins.   

Abstract

Cell panels have been used extensively in studies of polymorphism and disease associations within the major histocompatibility complex (MHC), but the results from these panels require continuous updates with the increasing availability of novel data. We present here an updated table of the typings of the 10IHW and 4AOH panels. Local data included are HFE, HERV-K(C4) and six microsatellites telomeric of HLA-A. Typings for class I, MICA (PERB11.1), MICB (PERB11.2), XA, XB, LMP2 and 10 microsatellites reported by others have also been consolidated in this table. The tabulation shows that the length of conservation in the human MHC is even more extensive than previously thought. Human MHC ancestral haplotypes are inherited as a conserved region of genomic sequence spanning some 6-8 megabases from the HLA class II region and beyond the HLA class I region up to and including the HFE gene. Numerous examples of historical recombinations were also observed.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11029610     DOI: 10.1046/j.1365-2370.2000.00226.x

Source DB:  PubMed          Journal:  Eur J Immunogenet        ISSN: 0960-7420


  8 in total

1.  Extended haplotype analysis in the HLA complex reveals an increased frequency of the HFE-C282Y mutation in individuals with multiple sclerosis.

Authors:  Justin P Rubio; Melanie Bahlo; Niall Tubridy; Jim Stankovich; Rachel Burfoot; Helmut Butzkueven; Caron Chapman; Laura Johnson; Mark Marriott; Grant Mraz; Brian Tait; Chris Wilkinson; Bruce Taylor; Terence P Speed; Simon J Foote; Trevor J Kilpatrick
Journal:  Hum Genet       Date:  2004-03-11       Impact factor: 4.132

Review 2.  Extreme genetic risk for type 1A diabetes in the post-genome era.

Authors:  Erin E Baschal; George S Eisenbarth
Journal:  J Autoimmun       Date:  2008-05-01       Impact factor: 7.094

3.  Vertebrate species profiling in one step using a single primer.

Authors:  Rebecca Laird; Silvana Gaudieri; Jemma Berry; Joseph Williamson; Jui-Sen Yang; Roger Dawkins
Journal:  Forensic Sci Med Pathol       Date:  2006-09       Impact factor: 2.007

4.  Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs.

Authors:  Mina John; David Heckerman; Ian James; Lawrence P Park; Jonathan M Carlson; Abha Chopra; Silvana Gaudieri; David Nolan; David W Haas; Sharon A Riddler; Richard Haubrich; Simon Mallal
Journal:  J Immunol       Date:  2010-03-15       Impact factor: 5.422

5.  Characterizing the diversity of MHC conserved extended haplotypes using families from the United Arab Emirates.

Authors:  Halima Alnaqbi; Guan K Tay; Sarah El Hajj Chehadeh; Habiba Alsafar
Journal:  Sci Rep       Date:  2022-05-03       Impact factor: 4.996

6.  HLA-class I markers and multiple sclerosis susceptibility in the Italian population.

Authors:  L Bergamaschi; M A Leone; M E Fasano; F R Guerini; D Ferrante; E Bolognesi; N Barizzone; L Corrado; P Naldi; C Agliardi; E Dametto; M Salvetti; A Visconti; D Galimberti; E Scarpini; M Vercellino; R Bergamaschi; F Monaco; D Caputo; P Momigliano-Richiardi; S D'Alfonso
Journal:  Genes Immun       Date:  2009-11-12       Impact factor: 2.676

7.  Segregation Analysis of Genotyped and Family-Phased, Long Range MHC Classical Class I and Class II Haplotypes in 5 Families With Type 1 Diabetes Proband in the United Arab Emirates.

Authors:  Guan K Tay; Halima Al Naqbi; Aurélie Mawart; Zahrah Baalfaqih; Anoud Almaazmi; Asma Deeb; Habiba Alsafar
Journal:  Front Genet       Date:  2021-06-30       Impact factor: 4.599

8.  Haplotype analysis of the HFE gene among populations of Northern Eurasia, in patients with metabolic disorders or stomach cancer, and in long-lived people.

Authors:  S V Mikhailova; V N Babenko; D E Ivanoshchuk; M A Gubina; V N Maksimov; I G Solovjova; M I Voevoda
Journal:  BMC Genet       Date:  2016-06-17       Impact factor: 2.797

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.